Team:USTC CHINA/Project/Overview

From 2013.igem.org

(Difference between revisions)
Line 61: Line 61:
         <div id="overview-bar" class="bassic-bar">
         <div id="overview-bar" class="bassic-bar">
         <h1>Overview</h1>
         <h1>Overview</h1>
-
         <p>T-VACCINE——A vaccine that can initiate immune response by penetrating the skin with the aid of transdermal peptide. From now on, injections are simply history! Based on the theory of user-friendly, a special group of engineering bacteria which produce T-VACCINE is used to create a brand-new "band-aid" that can serve as a guardian of our health .</p>
+
         <p>In our world, billions of people suffer from contagion, however, only part of them can be prevented by proper vaccine. Many disadvantages limit the usage of traditional vaccine especially in developing countries. </p>
<div class="img-left-side">
<div class="img-left-side">
-
<img src="https://static.igem.org/mediawiki/2013/c/c7/2013ustc-china_tvaccine1.png" width="300" height="200">
+
<img src="https://static.igem.org/mediawiki/igem.org/e/ec/2013ustc-china_traditional_vaccine_transport.jpg" width="300" height="200" />
 +
<p>Traditional vaccine,Requirements in shipping,Medical professionals, High-Cost, Contaminated needle</p>
</div>
</div>
-
<p>We have found a kind of transdermal peptide TD-1——a magical molecule that not only enhances the permeability of the skin but also draw filamentous bacteriophages into the skin. By combining the gene fragments of antigen, immune adjuvant LTB and Luman-recruiting factor TNLFα with that of the transdermal peptide, our team got the permeable fusion  protein. In order to obtain large amount of extracelluar protein, we chose bacillus subtilis WB800N as our expression engineering bacteria. At last, the universality of our experimental method is verified by the adoption of various antigen of existing vaccine, such as HBsAg, PA and AG85B.</p>
+
<p>This year, our project focused on a revolutionary vaccine delivery. We chose bacillus subtilis as chassis to establish a transdermal vaccine fresh secreting band-aid which consists of four engineering b.subtilis, each of them carries a gene circuit independently.</p>
-
        </div>
+
-
        <div id="aim-bar" class="bassic-bar">
+
-
        <h1>Project contains</h1>
+
-
        <p>For in situ transdermal vaccine is real a giant project, we devide it into four lab parts. And we expect to achieve following goals.</p>
+
-
        <div id="aim-bar-col">
+
-
        <h2>Antigen</h2>
+
<div class="img-left-side">
<div class="img-left-side">
-
<img src="https://static.igem.org/mediawiki/2013/6/62/2013ustc-china_HBsAg.png" width="300" height="200">
+
<img src="https://static.igem.org/mediawiki/2013/archive/e/ed/20130923171924!2013igemustc_Standardization.png" width="300" height="200" />
 +
</div>
 +
<p>By using an excellent transdermal peptide TD1, three of them could express a serious of fusion proteins(antigen, 2 kinds of adjuvants) which could penetrating the skin and work as traditional vaccine molecule.The fourth type of them is our “reporter” which could notify users whether the band-aid works well and when they could stick or tear off the patch. Moreover we designed a reliable suicide system in bacillus subtilis for the very first time in iGEM. So it would be OK if our users tear patches off and throw them away. Cheap and convenient, we just create a world without needle. </p>
 +
<div class="img-left-side">
 +
        <img src="https://static.igem.org/mediawiki/2013/6/6c/2013ustc-china_needle-aids.jpg"width="300" height="200" />   
 +
</div>
</div>
</div>
-
        <p>As the main part of T-vaccine, TD-1 is fused with antigen protein, so it can penetrate the skin and present antigen. We had designed there kinds of vaccine, which are against hepatitis B, TB and anthrax. Our ELISA test and mice test had proved their antigenicity and immunogenicity,thereby proving that T-vaccine can be generally used.</p></div>
 
-
        <div id="aim-bar-col">
 
-
        <h2>adjuvant</h2>
 
-
        <p>Similar with traditional injection vaccine, adjuvant should be added into vaccine to ensure immunity. We fused TD-1 with LTB. LT has adjuvant activity and can assist foreign antigen to induce the body to produce systemic immune response. The B submit of LTB protein has no toxic effect and it also works.</p></div>
 
-
        <div id="aim-bar-col">
 
-
        <h2>TNFα</h2>
 
-
        <p>TNFα can recruit Langerhans cell(LC), which work as antigen-presenting cells around epidermis, and improved LC’s transmission to adjacent lymph node. Because this circuit is quite similar with 1# and 2# ,while its effect might be difficult to certified, so we delay the schedule of this part. 3# is the only circuit which has not been built or tested.</p></div>
 
-
        <div id="aim-bar-col">
 
-
        <h2>Device</h2>
 
-
        <p>*****邵雪盈速度来救******</p></div>
 
-
        </div>
 
</div>
</div>
<div class="rightbar">
<div class="rightbar">

Revision as of 15:37, 26 September 2013

Overview

In our world, billions of people suffer from contagion, however, only part of them can be prevented by proper vaccine. Many disadvantages limit the usage of traditional vaccine especially in developing countries.

Traditional vaccine,Requirements in shipping,Medical professionals, High-Cost, Contaminated needle

This year, our project focused on a revolutionary vaccine delivery. We chose bacillus subtilis as chassis to establish a transdermal vaccine fresh secreting band-aid which consists of four engineering b.subtilis, each of them carries a gene circuit independently.

By using an excellent transdermal peptide TD1, three of them could express a serious of fusion proteins(antigen, 2 kinds of adjuvants) which could penetrating the skin and work as traditional vaccine molecule.The fourth type of them is our “reporter” which could notify users whether the band-aid works well and when they could stick or tear off the patch. Moreover we designed a reliable suicide system in bacillus subtilis for the very first time in iGEM. So it would be OK if our users tear patches off and throw them away. Cheap and convenient, we just create a world without needle.

Project

Retrieved from "http://2013.igem.org/Team:USTC_CHINA/Project/Overview"